NUMD
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $0 | -$6,377 |
| 2025 Q4 | -0.00 | $0 | -$35,054 |
| 2025 Q3 | -0.00 | $0 | -$13,083 |
| 2025 Q2 | -0.00 | $0 | $158 |
| 2025 Q1 | -0.00 | $0 | $0 |
| 2024 Q4 | -0.00 | $600 | -$1,668 |
| 2024 Q3 | -0.00 | $0 | $0 |
| 2024 Q2 | -0.00 | $0 | -$2,315 |